50 Stocks Moving In Tuesday's Mid-Day Session

Loading...
Loading...

Gainers

  • Pioneer Power Solutions PPSI shares jumped 235.7% to $5.27.
  • Comstock Holding Companies, Inc. CHCI gained 31% to $3.3389.
  • Alteryx, Inc. AYX climbed 26.4% to $143.98 after the company raised its sales guidance for the third quarter and announced Mark Anderson as new CEO.
  • Westwater Resources, Inc. WWR shares gained 26.1% to $10.44 after jumping over 87% on Monday. The company holds minerals rights for lithium and uranium deposits and strength appears related to momentum in lithium names amid EV battery interest.
  • Piedmont Lithium Limited PLL shares climbed 25.5% to $43.50. Piedmont Lithium shares jumped around 33% on Monday on continued strength after the company in late September announced it signed a sales agreement with Tesla.
  • China Recycling Energy Corporation CREG gained 22% to $4.27.
  • TransAct Technologies Incorporated TACT climbed 21.5% to $6.20 after the company raised its Q3 sales guidance.
  • IKONICS Corporation IKNX gained 19.2% to $3.98.
  • Lightbridge Corporation LTBR rose 18.2% to $4.825.
  • Kiniksa Pharmaceuticals, Ltd. KNSA surged 18.1% to $18.71 after reporting data from Phase 2 trial of mavrilimumab in giant cell arteritis. The trial achieved both the primary and secondary efficacy endpoints with statistical significance.
  • ReneSola Ltd SOL gained 16% to $2.4698. ReneSola, last month, priced 2.5 million ADS offering at $2 per ADS.
  • XpresSpa Group, Inc. XSPA shares rose 15.4% to $2.6050 after gaining around 18% on Monday.
  • Polar Power, Inc. POLA jumped 14.9% to $4.375.
  • Cogent Biosciences Inc. COGT gained 14.9% to $2.70.
  • Humanigen, Inc. HGEN jumped 14.8% to $13.94. Humanigen, on Friday, issued updates on Lenzilumab in COVID-19 program.
  • Group 1 Automotive, Inc. GPI rose 14.7% to $117.00 after the company issued Q3 preliminary EPS above analyst estimates and announced a $200 million buyback. The company also said it intends to reinstate its dividend.
  • Jaguar Health, Inc. JAGX gained 14.6% to $0.3553 after the company announced it has met the financial condition for the sale of royalty rights for Mytesi.
  • Neuronetics, Inc. STIM gained 14.6% to $5.93. BTIG reiterated Neuronetics with a Buy and raised the price target from $6 to $10.
  • TOMI Environmental Solutions, Inc. TOMZ gained 13.4% to $9.70 after gaining over 15% on Monday. TOMI Environmental Solutions recently reported uplisting to the Nasdaq Capital Market.
  • DBV Technologies S.A. DBVT rose 10% to $1.8150.
  • Naked Brand Group Limited NAKD shares rose 8.5% to $0.1232 as the company’s subsidiary, Bendon, entered into a settlement deal with Timothy Connell, William Gibson and Ivory Castle.
  • Gamida Cell Ltd. GMDA rose 8.1% to $4.54 after the company announced its Phase 3 clinical study of Omidubicel met all three of its secondary endpoints.
  • Emerald Holding, Inc. EEX shares rose 7.9% to $2.50 after the company announced it authorized a $20 million buyback program.
  • Xtant Medical Holdings, Inc. XTNT rose 7.8% to $1.6388 after the company announced it has regained compliance with the NYSE American continued listing standards. Xtant Medical shares climbed over 91% on Friday after the company announced the closing of debt restructuring.
  • Invitae Corporation NVTA gained 7.2% to $48.67 after it was announced Taysha Gene Therapy and the company partnered to enabled rapid access to genetic testing and earlier diagnosis of patients with CNS disease and large-market indications.
  • Himax Technologies, Inc. HIMX rose 7% to $3.7033 following strong preliminary results for the third quarter.
  • ChromaDex Corporation CDXC rose 6.6% to $4.34. ChromaDex highlighted publicatoin of study results showing 'nutritional protocol including nicotinamide riboside plus standard of care reduces recovery time in COVID-19 patients by nearly 30%.'
  • Tata Motors Limited TTM rose 6.6% to $9.81.
  • BioNTech SE BNTX rose 6.5% to $85.88. BioNTech and Pfizer reported the initiation of rolling submission to the EMA for SARS-CoV-2 vaccine candidate BNT162b2.
  • Can Fite Biopharma ADR CANF gained 5.6% to $1.85 after an independent data monitoring committee recommended the company to continue with Phase III psoriasis study.
  • Trinseo S.A. TSE gained 4% to $28.61 after Jefferies upgraded the stock from Hold to Buy and raised its price target from $28 to $35 per share.

Check out these big penny stock gainers and losers

Losers

  • Corbus Pharmaceuticals Holdings, Inc. CRBP shares dipped 36.5% to $1.20 after the company announced its Phase 2b study of Lenabasum for treatment of cystic fibrosis did not meet the primary endpoint.
  • Miragen Therapeutics, Inc. MGEN fell 21.1% to $0.60 after the company announced that it conducted an internal review of preliminary topline data from its Phase 2 SOLAR clinical trial of cobomarsen in patients with Cutaneous T-Cell Lymphoma. The press release said preliminary data in 37 patients suggest that cobomarsen lacks a compelling result for the study's primary endpoint.
  • Axovant Gene Therapies Ltd. AXGT fell 21% to $4.4501. Axovant reported positive six-month follow-up data from second cohort of SUNRISE-PD Phase 2 trial of AXO-Lenti-PD gene therapy.
  • Palomar Holdings, Inc. PLMR shares fell 19.4% to $87.77. Palomar Holdings said it expects pretax catastrophe losses of $34 million to $38 million, net of reinsurance, during the third quarter.
  • Hyliion Holdings Corp. HYLN dropped 13.4% to $33.90. On Friday, Hyliion shares dropped 12% in first day of post-SPAC merger trading.
  • Iovance Biotherapeutics, Inc. IOVA fell 12.5% to $28.05. Following a recent Type B meeting with the FDA, Iovance Biotherapeutics said it has not been able to agree with the FDA on the required potency assays to fully define its tumor-infiltrating lymphocyte therapy lifileucel in metastatic melanoma, which is required as part of a BLA submission. Wells Fargo downgraded Iovance Biotherapeutics from Overweight to Equal-Weight and lowered the price target from $49 to $29.
  • Social Capital Hedosophia Holdings Corp. III IPOC fell 12% to $11.17. Alphabet and Sequoia-backed insurance startup Clover Health plans to go public via a merger with blank check company Social Capital Hedosophia Holdings Corp. III, reports the New York Times.
  • ProPhase Labs, Inc. PRPH dipped 11.8% to $6.08. ProPhase Labs recently announced plans to explore the acquisition of one or more CLIA accredited labs suitable for COVID-19 and other testing.
  • Artelo Biosciences, Inc. ARTL fell 11% to $0.97 after surging over 26% on Monday. Artelo Biosciences, last week, received Ethics Committee approval in the UK to commence its Phase I/II study of ART27.13.
  • Nam Tai Property Inc. NTP dropped 10.3% to $6.19. Nam Tai Property shares tumbled 26% on Monday as the company raised $170 million through private placement transaction.
  • Inpixon INPX fell 9.8% to $1.1099. Inpixon yesterday announced plans to buy Nanotron for $8.7 million.
  • Lithium Americas Corp. LAC shares dipped 9.4% to $14.37.
  • JinkoSolar Holding Co., Ltd. JKS dropped 7.9% to $ 44.51.
  • Y-mAbs Therapeutics, Inc YMAB shares fell 7.7% to $38.51 after the company reported it received a Refusal to File letter from the FDA regarding the Biologics License Application for omburtamab for the treatment of patients with neuroblastoma.
  • Greenpro Capital Corp. GRNQ shares fell 6.4% to $1.7410. Greenpro Capital shares jumped over 70% on Monday after the company reported it intends to incubate a satellite communication venture.
  • Pacific Drilling S.A. PACD fell 6.4% to $0.2751 after rising 5% on Monday.
  • Logitech International S.A. LOGI fell 5.6% to $76.28. Logitech is expected to release quarterly earnings on October 19.
  • LM Funding America, Inc. LMFA fell 5.3% to $0.5672 after declining around 8% on Monday.
  • PIMCO Dynamic Income Fund PDI fell 4.8% to $24.62 after the company announced a public offering of 3 million shares of common stock.
Loading...
Loading...
Posted In: NewsIntraday UpdateMarketsMoversTrading IdeasComputer Storage & PeripheralsInformation TechnologyMid-Day MoversTop Gainers
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...